Recent Updates
Recently added Catalysts
CLGN Positive Sentiment Score: 65/100

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

Tuesday, March 14, 2023 2 min read
Key Takeaway: CollPlant Biotechnologies has announced that it will report its financial results for the year ended December 31, 2022, on March 29, 2023. Following the financial report, the company will host a conference call and webcast to update investors on its performance and other corporate developments. CollPlant specializes in regenerative and aesthetic medicine, particularly through the use of its recombinant human collagen technology in tissue repair and organ manufacturing. The company has previously partnered with Allergan to develop dermal fillers, highlighting its potential in the market.

Market Sentiment Analysis

POSITIVE FACTORS

  • CollPlant is set to announce its full-year financial results, which may provide insight into its growth and performance.
  • The company is actively engaging with investors by providing a platform for questions before the conference call.
  • There is a focus on innovative technologies in regenerative and aesthetic medicine that may indicate potential for future market expansion.

Full Press Release Details

- Conference call to be held on March 29, 2023 at 10:00 am U.S. EDT -
REHOVOT, Israel, March 14, 2023 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and organ manufacturing, today announced that it will report financial results for the full year ended December 31, 2022, on March 29, 2023, before the market open. The Company will then host a conference call and webcast to discuss its financial results along with corporate updates on March 29th at 10:00 am Eastern Time.
Conference call information
To participate in the conference call, please use the dial-in information below:
U.S. investors: 1-877-407-9716
Investors outside of the U.S.: 1-201-493-6779
Conference ID: 13736701
Note, you can avoid long wait times for the operator by using the Call me™ feature and clicking the link below 15 minutes prior to the scheduled call start time:
https://callme.viavid.com/viavid/?callme=true&passcode=13728588&h=true&info=company&r=true&B=6
Submit questions to management in advance of the call
To ask management a question ahead of the call, please email John Mullaly at LifeSci Advisors LLC up until 24 hours before the event at [email protected].
To participate in listen-only mode and to view slides corresponding to the company conference call, please visit the News & Events section of the CollPlant Investor Relations website where a link will be posted.
A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the Company's website for a limited time.
CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics. The Company's products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing, and are ushering in a new era in regenerative and aesthetic medicine.
In 2021 CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market.
For more information about CollPlant, visit http://www.collplant.com
Tel: + 972-73-2325600
Email: [email protected]

21 %

more press release views with

Frequently Asked Questions

When will CollPlant announce its financial results?

CollPlant will announce its financial results on March 29, 2023.

What time is the conference call scheduled for?

The conference call is scheduled for 10:00 am U.S. EDT on March 29, 2023.

How can I participate in the conference call?

U.S. investors can dial 1-877-407-9716 to participate in the call.

How do I submit questions before the call?

Email questions to John Mullaly at LifeSci Advisors LLC before the call.

Will there be a replay of the conference call?

Yes, a replay of the webcast will be available on the Company's website afterward.

Tags: CLGN Viatris Investor Conferences Healthcare CollPlant financial results conference call regenerative medicine
Last updated: Mar 14, 2023